CD8A and neoplasm: Genetic engineering approaches have been used to demonstrate that the overexpression of BATF and IRF4 negatively regulated the expression of TOX in CD8 T cells, resulting in the generation of potent antitumorigenic CD8 T cells within the tumor microenvironment50.